$11.02
-0.75-6.37%
Last update: Nov 5, 6:58 PM
Vir Biotechnology Inc
VIRNASDAQ
The average analyst price target for Vir Biotechnology is $20.91, 82.9% above the current price. Of 10 analysts, 9 rate it Buy and 1 Hold. Targets range from $12 to $31. The latest change came on Nov 5, 2026, when Needham raised its price target on Vir Biotechnology from $18 to $20 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
